Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Beta-1b and Hydroxychloroquine for COVID-19
NCT04350281Phase 2Completed
- Sponsor
- The University of Hong Kong
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1b in coronavirus disease 2019 (COVID-19), sponsored by The University of Hong Kong. Started Apr 2020; status: completed.
02
Drugs
interferon beta-1b
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04350281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04350281.